March 3, 2021

Elanco introduces vaccine for bovine pneumonia and BRD

Elanco Animal Health Incorporated has introduced NUPLURA PH+, providing fast, smooth and flexible protection against bovine respiratory disease (BRD), Bovine Veterinarian reported.

The new vaccine builds on the proven performance of NUPLURA PH against Mannheimia haemolytica, while adding protection against common viral causes of BRD, including BVD Types 1 and 2 and IBR.

NUPLURA PH+ provides protective immunity against M. haemolytica in as little as 10 days, which is the fastest immunity claim on the market. M. haemolytica is the primary bacterial cause of pneumonia in cattle.

"With NUPLURA PH+, the fastest BRD vaccine on the market just got better. Producers can now target bacterial and viral BRD pathogens with one vaccination. This means less stress on the animal, less labour and less time to administer," says Brett Terhaar, Elanco Animal Health technical consultant. "Producers have the flexibility to deliver the right protection their herds need, at the right time."

NUPLURA PH+ is gentle and safe to use on calves as young as 28 days. Field trials show that calves vaccinated with NUPLURA PH+ stay on feed and water with minimal post-vaccination reactions. Calves can then devote energy to growth and productivity.